BMO Capital Upgrades Incyte to Market Perform, Raises Price Target to $94
Incyte Corporation
Incyte Corporation INCY | 0.00 |
BMO Capital analyst Evan Seigerman upgrades Incyte (NASDAQ:
INCY) from Underperform to Market Perform and raises the price target from $75 to $94.
